In addition to providing high-quality, culturally competent healthcare and supportive services targeted to LGBTQ communities and people living with HIV/AIDS, Callen-Lorde also serves as a center of excellence – helping to train the future leaders in LGBT health while blazing new trails through research and other strategic partnerships. Below are our current research studies:
Callen-Lorde is collaborating with the NYS Psychiatric Institute at Columbia University on a study that uses Nuvigil and counseling to help alleviate HIV related fatigue.
HIV+ and experiencing fatigue? Is HIV interfering with your ability to gain employment or return to work?
HIV+ people may experience persistent fatigue that interferes with vocational goals. Certain medical and other exclusions apply. Please note: The same vocational counseling is also offered to HIV+ individuals who aren’t experiencing significant fatigue.
What is Nuvigil?
Nuvigil (armodafinil) has FDA approval to treat excessive daytime sleepiness. We are using it to treat fatigue.
What is involved?
This research program offers up to 4 months of Nuvigil. Once energy improves, counseling is provided to heal you reach your employment goal.
Dr. Judith Rabkin – (646) 774-8075 / email@example.com
Stephanie Pena – (212) 271-7238 / firstname.lastname@example.org
Promoting Action Towards Health (PATH) is a research study for HIV-positive gay and bisexual men recently diagnosed within the last three months. PATH is designed to promote positive health behaviors, reduce HIV risk, and increase self-awareness through one-on-one counseling. All participants of PATH can earn up to $225 for participation. For more information, email email@example.com
The PRIDE Study is the first large-scale, long-term health study of people who identify as lesbian, gay, bisexual, transgender, queer (LGBTQ), or another sexual or gender minority.
By participating in The PRIDE Study over time, your unique story teaches us about the health and well-being of LGBTQ people like you. Make your voice heard!